United States, European and Japanese Cancer Therapeutics Markets

 


Availability: In stock

 

Regular Price: USD 3,950

Special Price USD 2,765

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

Table of Contents

United States, European and Japanese Cancer Therapeutics Markets, Executive SummaryIntroduction to the U.S., European Union, and Japanese Cancer Therapeutics MarketIntroduction to the U.S., European Union, and Japanese Cancer Therapeutics MarketSummary of Major FindingsMarket Forecast and OpportunitiesCompetitive AnalysisTechnologiesConclusionsUnited States, European and Japanese Cancer Therapeutics Markets, Research Scope and MethodologyResearch ScopeObjectives and PurposeReport Structure and Market SegmentationResearch MethodologyResearch Methodology Approach for the World Cancer Therapeutics MarketForecast Model Market Model AssumptionsPresentation of Strategic Significance of Market Engineering Measurements Presentation of Strategic Significance of Market Engineering Measurements Market AgeRevenuesPotential RevenuesMarket Growth by Compound Annual Growth Rate (CAGR)Annual Market GrowthTarget Population IncidenceNumber of NDAs Awaiting Approval in Base YearNumber of CompetitorsMarket ConcentrationNumber of Products on the MarketProducts in DevelopmentUnited States, European and Japanese Cancer Therapeutics Markets, Total Market Overview and Industry ChallengesMarket Overview and DefinitionsMarket Overview and DefinitionsRevenue BreakoutRevenue Breakout by RegionRevenue Breakout by Disease SiteRevenue Breakout by Disease by RegionChallenges Facing the Pharmaceutical IndustryChallenges Facing the Pharmaceutical IndustryRecovering Research & Development Costs and Building Reserves for Future Drug DevelopmentConstant Entry of New Agents Increases Level of CompetitionOncologist Familiarity With Agents Used in Clinical Trials Creates Barriers to Entry In Other World MarketsUnited States, European and Japanese Cancer Therapeutics Markets, Current Drug Therapy OverviewIntroductionIntroductionAlkylating AgentsAnti-Tumor AntibioticsAnti-Tumor AntimetabolitesBiological Response ModifiersHormonesSteroidsMiscellaneous AntineoplasticsStrategic Analysis and Forecasts of the U.S., EU, and Japanese Breast Cancer Therapeutics MarketMarket Overview and DefinitionsMarket Overview and DefinitionsDisease OverviewTreatment OptionsCurrent Drug Therapy and PharmacologyMarket Engineering Research Measurement SystemMarket ForecastsTrends in Research and DevelopmentCompetitive StructureCompetitive StructureCompetitive Market Share Analysis: Winners, Losers, and WhyProduct Competitive BenchmarkingForecasts by Geographic RegionStrategic Analysis and Forecasts of the U.S., EU, and Japanese Lung Cancer Therapeutics MarketMarket Overview and DefinitionsMarket Overview and DefinitionsDisease OverviewDiagnostic CriteriaTreatment OptionsCurrent Drug Therapy and PharmacologyMarket Engineering Research Measurement SystemMarket ForecastsMarket and Technology TrendsTrends in Research and DevelopmentCompetitive EnvironmentCompetitive Market Share Analysis: Top Three Market Share Competitors and WhyForecasts by Geographic RegionStrategic Analysis and Forecasts of the U.S., EU, and Japanese Melanoma Therapeutics MarketMarket Overview and DefinitionsMarket Overview and DefinitionsDisease OverviewDiagnostic CriteriaTreatment OptionsCurrent Drug Therapy and PharmacologyMarket Engineering Research Measurement SystemMarket ForecastsTrends in Research and DevelopmentLate-Phase Melanoma TherapeuticsCompetitive StructureCompetitive StructureCompetitive Market Share Analysis: Winners, Losers, and WhyCompetitive Market Share Analysis: Winners, Losers, and WhyMarket Winners and WhyMarket Losers and WhyKey Products and Their CompetitorsKey Products and Their CompetitorsForecasts by Geographic RegionUnited StatesEuropeJapanStrategic Analysis and Forecasts of the U.S., EU, and Japanese Genital Organs Cancer Therapeutics MarketMarket Overview and DefinitionsMarket Overview and DefinitionsMarket ForecastsMarket Engineering Analysis of the World Uterine Cancer Therapeutics MarketMarket OverviewDisease OverviewMarket Engineering Measurement SystemMarket Engineering Measurement SystemMarket ForecastsMarket ForecastsMarket DriversMarket RestraintsTrends in Research and DevelopmentTrends in Research and DevelopmentCompetitive StructureCompetitive StructureCompetitive Market Share Analysis: Winners, Losers, and WhyKey Products and Their Competitors Key Products and Their Competitors Forecasts by Geographic RegionUnited StatesEuropeJapanMarket Engineering Analysis of the World Ovarian Cancer Therapeutics MarketMarket OverviewDisease OverviewMarket Engineering Measurement SystemMarket Engineering Measurement SystemMarket ForecastsMarket ForecastsMarket DriversMarket RestraintsTrends in Research and DevelopmentProducts in Research and DevelopmentOvarex–a Late-Phase Ovarian Cancer TherapyCompetitive StructureCompetitive StructureCompetitive Market Share Analysis: Winners, and WhyCompetitive Market Share Analysis: Winners, and WhyBristol-Myers Squibb CompanySmithKline BeechamKey Products and Their Competitors Key Products and Their Competitors Forecasts by Geographic RegionUnited StatesEuropeJapanMarket Engineering Analysis of the World Prostate Cancer Therapeutics MarketMarket OverviewDisease OverviewMarket Engineering Measurement SystemMarket Engineering Measurement SystemMarket ForecastsMarket ForecastsMarket DriversMarket RestraintsTrends in Research and DevelopmentTrends in Research and DevelopmentLate-Phase Prostate Cancer TherapeuticsCompetitive StructureCompetitive StructureCompetitive Market Share Analysis: Winners, Losers, and WhyKey Products and Their Competitors Key Products and Their Competitors Forecasts by Geographic RegionUnited StatesEuropeJapanStrategic Analysis and Forecasts of the U.S., EU, and Japanese Urinary Organs Cancer Therapeutics MarketMarket Overview and DefinitionsMarket Overview and DefinitionsMarket ForecastMarket Engineering Analysis of the World Bladder Cancer Therapeutics MarketMarket OverviewDisease OverviewMarket Engineering Measurement SystemMarket ForecastsTrends in Research and DevelopmentAD32–Bladder Cancer Therapy in Late-Phase Development Competitive StructureKey Products and Their CompetitorsForecasts by Geographic RegionMarket Engineering Analysis of the World Renal Cell Cancer Therapeutics MarketMarket OverviewDisease OverviewMarket Engineering Measurement SystemMarket ForecastsTrends in Research and DevelopmentLate-Phase RCC TherapeuticsCompetitive StructureCompetitive Market Share Analysis: Winners, and WhyKey Products and Their CompetitorsForecasts by Geographic RegionStrategic Analysis and Forecasts of the World Blood and Lymph Cancer Therapeutics MarketStrategic Analysis and Forecasts of the Total MarketMarket Definitions and OverviewMarket ForecastsMarket DriversMarket RestraintsMarket Engineering Analysis of the World Leukemia Therapeutics MarketMarket OverviewMarket Engineering Measurement SystemMarket ForecastsMarket, and Technology TrendsTrends in Research and DevelopmentCompetitive EnvironmentCompetitive Market Share Analysis: Top Three Market Share Competitors and WhyForecasts by Geographic RegionMarket Engineering Analysis of the World Hodgkin's Disease Therapeutics MarketMarket OverviewMarket Engineering Measurement SystemMarket ForecastsMarket and Technology TrendsCompetitive EnvironmentCompetitive Market Share Analysis: Top Market Share Competitors and WhyForecasts by Geographic RegionMarket Engineering Analysis of the World Non-Hodgkin's Lymphoma Therapeutics MarketMarket OverviewMarket Engineering Measurement SystemMarket ForecastsMarket and Technology TrendsTrends in Research and DevelopmentCompetitive EnvironmentCompetitive Market Share Analysis: Top Three Market Competitors and WhyForecasts by Geographic RegionStrategic Analysis and Forecasts of the World Gastrointestinal Cancer Therapeutics MarketStrategic Analysis and Forecasts of the Total MarketMarket Definitions and OverviewMarket ForecastsMarket DriversMarket RestraintsMarket Engineering Analysis of the World Gastric Cancer Therapeutics MarketMarket OverviewCurrent Drug Therapy, and PharmacologyMarket Engineering Measurement SystemMarket ForecastsMarket and Technology TrendsCompetitive EnvironmentCompetitive Market Share Analysis: The Top Market Share Competitors, and WhyForecasts by Geographic RegionMarket Engineering Analysis of the World Colorectal Cancer Therapeutics MarketMarket OverviewClinical Drug Therapy, and PharmacologyMarket Engineering Measurement SystemMarket ForecastsMarket, and Technology TrendsTrends in Research, and DevelopmentCompetitive EnvironmentCompetitive Market Share Analysis: Top Market Share Competitors, and WhyForecasts by Geographic RegionMarket Engineering Analysis of the World Pancreatic Cancer Therapeutics MarketMarket OverviewDisease OverviewClinical Drug Therapy, and PharmacologyMarket Engineering Measurement SystemMarket ForecastsMarket, and Technology TrendsTrends in Research and DevelopmentCompetitive EnvironmentCompetitive Market Share Analysis: Top Market Share Competitors and WhyForecasts by Geographic RegionStrategic Analysis and Forecasts of the U.S., EU, and Japanese Brain Tumor Therapeutics MarketMarket Overview and DefinitionsMarket Overview and DefinitionsDisease OverviewDiagnostic CriteriaTreatment OptionsCurrent Drug Therapy and PharmacologyMarket Engineering Research Measurement SystemMarket ForecastMarket and Technology TrendsTrends in Research and DevelopmentCompetitive EnvironmentCompetitive Market Share Analysis: Top Three Market Share Competitors and WhyForecast by Geographic RegionThe Role of Market Engineering in the Pharmaceutical BusinessIntegrating Market Engineering into Business PlanningIntegrating Market Engineering into Business PlanningCurrent Company Status LocationDesired StatusDeveloping the StrategyImplementing the StrategyUsing Market Engineering to Address Industry Challenges, Market Trends, and OpportunitiesUsing Market Engineering to Address Industry Challenges, Market Trends, and OpportunitiesMarket Engineering Monitoring of the Pharmaceutical IndustryThe Purpose of Market Engineering MonitoringHow to Design a Successful Monitoring ProgramFrost & Sullivan Strategic Recommendations for Further Research




Related Research

Release Date : 25-Jul-17

Region : Global

Release Date : 24-Jul-17

Region : Global

Release Date : 24-Jul-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.